BRPI1013835B8 - method for producing biologically active material of nanoparticle and/or microparticle, composition comprising said material, pharmaceutical composition, use thereof, and method for producing a pharmaceutical composition, a veterinary product and an agricultural product - Google Patents

method for producing biologically active material of nanoparticle and/or microparticle, composition comprising said material, pharmaceutical composition, use thereof, and method for producing a pharmaceutical composition, a veterinary product and an agricultural product

Info

Publication number
BRPI1013835B8
BRPI1013835B8 BRPI1013835A BRPI1013835A BRPI1013835B8 BR PI1013835 B8 BRPI1013835 B8 BR PI1013835B8 BR PI1013835 A BRPI1013835 A BR PI1013835A BR PI1013835 A BRPI1013835 A BR PI1013835A BR PI1013835 B8 BRPI1013835 B8 BR PI1013835B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
producing
biologically active
nanoparticle
microparticle
Prior art date
Application number
BRPI1013835A
Other languages
Portuguese (pt)
Inventor
Russell Adrian
Dodd Aaron
Meiser Felix
Norret Marck
H Bosch William
Original Assignee
Iceutica Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901747A external-priority patent/AU2009901747A0/en
Application filed by Iceutica Pty Ltd filed Critical Iceutica Pty Ltd
Priority claimed from PCT/AU2010/000467 external-priority patent/WO2010121323A1/en
Publication of BRPI1013835B1 publication Critical patent/BRPI1013835B1/en
Publication of BRPI1013835B8 publication Critical patent/BRPI1013835B8/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

método para a produção de pós de nanopartícula e de micropartícula comerciais a presente invenção se refere aos métodos para produção de pós de nanopartículas e micropartículas de um material biologicamente ativo que possui propriedades aprimoradas de manuseio pulverulento tornando os pós adequados para o uso comercial utilizando processos de moagem a seco bem como composições compreendendo tais materiais, medicamento produzidos usando referidos materiais biologicamente ativos em forma particulada e/ou composições, e a métodos de tratamento de um animal, incluindo homem, usando uma quantidade terapeuticamente eficaz dos referidos materiais biologicamente ativos administrados por meio dos referidos medicamentos.Method for the production of commercial nanoparticle and microparticle powders The present invention relates to methods for producing nanoparticle and microparticle powders from a biologically active material that has improved powder handling properties making the powders suitable for commercial use using processes of dry milling as well as compositions comprising such materials, medicament produced using said biologically active materials in particulate form and/or compositions, and methods of treating an animal, including man, using a therapeutically effective amount of said biologically active materials administered by means of of said drugs.

BRPI1013835A 2009-04-24 2010-04-23 method for producing biologically active material of nanoparticle and/or microparticle, composition comprising said material, pharmaceutical composition, use thereof, and method for producing a pharmaceutical composition, a veterinary product and an agricultural product BRPI1013835B8 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17230009P 2009-04-24 2009-04-24
AU2009901747A AU2009901747A0 (en) 2009-04-24 Method for the Production of Commercial Nanoparticle and Microparticle Powders
US61/172,300 2009-04-24
AU2009901747 2009-04-24
PCT/AU2010/000467 WO2010121323A1 (en) 2009-04-24 2010-04-23 Method for the production of commercial nanoparticle and microparticle powders

Publications (2)

Publication Number Publication Date
BRPI1013835B1 BRPI1013835B1 (en) 2021-04-20
BRPI1013835B8 true BRPI1013835B8 (en) 2021-05-25

Family

ID=65905676

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013835A BRPI1013835B8 (en) 2009-04-24 2010-04-23 method for producing biologically active material of nanoparticle and/or microparticle, composition comprising said material, pharmaceutical composition, use thereof, and method for producing a pharmaceutical composition, a veterinary product and an agricultural product

Country Status (2)

Country Link
JP (1) JP2019048854A (en)
BR (1) BRPI1013835B8 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717677B (en) * 2022-03-31 2023-09-26 广东粤港澳大湾区国家纳米科技创新研究院 Nano gold non-woven fabric and preparation method and application thereof
CN115105532A (en) * 2022-05-31 2022-09-27 复旦大学附属中山医院 Preparation method of human bile freeze-dried powder
CN116004451B (en) * 2022-12-08 2023-07-18 贵州大学 Composite particle type microbial agent and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4117811B2 (en) * 1997-04-22 2008-07-16 日本化薬株式会社 Flutamide preparation and its production method
SA99191255B1 (en) * 1998-11-30 2006-11-25 جي دي سيرل اند كو celecoxib compounds
JP2004099442A (en) * 2002-09-04 2004-04-02 Nisshin Pharma Inc Pharmaceutical preparation containing sparingly soluble drug and method for producing the same
CA2631493A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
UA110773C2 (en) * 2009-04-24 2016-02-25 Айсьютіка Пті Лтд Method of producing powder containing nano- and microparticles

Also Published As

Publication number Publication date
JP2019048854A (en) 2019-03-28
BRPI1013835B1 (en) 2021-04-20

Similar Documents

Publication Publication Date Title
BRPI1014276B8 (en) production of encapsulated nanoparticles on a commercial scale
MY179872A (en) Method for the production of commercial nanoparticle and microparticle powders
MY159098A (en) Production of encapsulated nanoparticles at high volume fractions
BRPI1014275B8 (en) composition comprising indomethacin particles dispersed in at least two partially ground mill materials
BRPI1014278B8 (en) method for producing a dosage form comprising metaxolone, dosage form, pharmaceutical composition comprising said dosage form and use thereof
PH12015500301B1 (en) A novel formulation of diclofenac
PH12016500746A1 (en) A novel formulation of meloxicam
NZ595985A (en) A novel formulation of naproxen
BRPI1013835B8 (en) method for producing biologically active material of nanoparticle and/or microparticle, composition comprising said material, pharmaceutical composition, use thereof, and method for producing a pharmaceutical composition, a veterinary product and an agricultural product
PH12015501811A1 (en) Production of encapsulated nanoparticles at high volume fractions
NZ710321A (en) Production of encapsulated nanoparticles at high volume fractions
TH135892A (en) The new Meloxikam recipe
TH125551A (en) Production of nanoparticles trapped at commercial sizes
TH135130B (en) Methods for improving the solubility profile of bioactive materials.
TH140025A (en) Methods for the production of powder, nanoparticles and commercial micro-particles.
TH135892B (en) The new Meloxikam recipe
TH125552A (en) Production of nanoparticles trapped at high volumetric ratios
TH125551B (en) Production of nanoparticles trapped at commercial sizes
TH135130A (en) Methods for improving the solubility profile of bioactive materials.
TH125552B (en) Production of nanoparticles trapped at high volumetric ratios

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2667 DE 15-02-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.